Table 3. FACS analysis of the cellular populations present in the thymus three months after competitive bone marrow transplantation.
Donor | 1∶1 | WT:WT | 1∶1 | WT:KO | ||
% cells | gated | CD45.1+ | CD45.2+ | gated | CD45.1+ | CD45.2+ |
FSC-A/SSC-A | 95.5 | 35.7 | 63.6 | 95.5 | 19.4** | 79.9** |
CD19+ | 0.4 | 38.1 | 56.5 | 0.5 | 33.7 | 58.3 |
CD19− | 99.5 | 35.8 | 63.7 | 99.5 | 19.4** | 80.0** |
CD8−CD4+ | 9.2 | 39.4 | 60.5 | 10.9 | 21.4** | 78.4** |
CD8+CD4+ | 86.3 | 35.4 | 64.3 | 84.2 | 19.0** | 80.5** |
CD8+CD4− | 2.6 | 41.8 | 57.8 | 3.2 | 22.4** | 77* |
CD8−CD4− | 1.9 | 19.4 | 45.9 | 1.7 | 17.4 | 69.3 |
Distribution of CD45.1+ and CD45.2+ cells in the thymus of recipient mice 3 months after bone marrow transplantation. CD45.1+ WT and CD45.2+ WT or CD45.2+ KO donor cells were mixed at a 1∶1 ratio prior to injection into recipient CD45.1+ mice. The percentage of total cells gated and the percentage of CD45.1+ or CD45.2+ cells for any given gate are shown. Significance was assessed using Student’s t-test and p-values are indicated as *p<0.05, **p<0.01, ***p<0.001.